Package 60505-4453-6

{"route": ["ORAL"], "spl_id": "640ebad3-45ab-9163-21fb-b0f3117cfa82", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0360505445264"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1666332"], "spl_set_id": ["2c59ea45-6113-6e9e-70b5-3b8c8b3d89b6"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (60505-4453-6)", "package_ndc": "60505-4453-6", "marketing_start_date": "20251031"}], "brand_name": "Ticagrelor", "product_id": "60505-4453_640ebad3-45ab-9163-21fb-b0f3117cfa82", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "60505-4453", "generic_name": "Ticagrelor", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "60 mg/1"}], "application_number": "ANDA208584", "marketing_category": "ANDA", "marketing_start_date": "20251031", "listing_expiration_date": "20261231"}